Choosing a Clinic After Recurrent Pregnancy Loss

Is choosing a clinic for recurrent loss a different search?

Yes. Recurrent pregnancy loss — the clinical name for multiple miscarriages, generally two or more — is its own problem, distinct from trouble conceiving, and it calls for a clinic that investigates why the losses are happening before it reaches for treatment. That reframes the whole search: you are not shopping for the highest IVF headline, you are looking for a program that evaluates thoroughly and counsels with honesty.

Many people arrive at a fertility practice after losses expecting to be handed an IVF plan. Careful recurrent-loss care usually begins earlier, with a structured evaluation. So the first thing to judge about a clinic is not its marketing but its instinct — does it want to understand your history, or sell you a cycle?

What a clinic's first move tells you

A strong recurrent-loss program leads with evaluation, not a treatment sale. Before proposing IVF, it looks for treatable contributors, and whether it offers that structured recurrent loss workup at all is the clearest early signal of how it practices. The specifics of that testing — from uterine imaging to karyotype testing of both partners — are a subject of their own; for choosing a clinic, what matters is that the practice runs the evaluation rather than skipping past it.

If a clinic proposes IVF at the first visit without discussing the workup after recurrent pregnancy loss, that tells you something about its priorities. Ask directly what its evaluation includes and why it is or is not recommending each test. A practice that can explain its reasoning is showing you the judgment you are actually hiring.

How to read a clinic's success-rate data

Every US clinic that performs IVF is required by federal law to report its outcomes, and the CDC publishes them, so a clinic's numbers are public rather than something you take on faith 1Ref 1Centers for Disease Control and Prevention (2024).ART Success Rates.That US ART clinics are required by federal law to report their outcomes and that the CDC publishes them, so a clinic's success data is public.. But for recurrent loss, those live-birth-per-cycle figures answer a narrower question than the one you are asking. They measure treatment outcomes across a clinic's whole patient mix; they do not capture how well a practice evaluates and manages miscarriage.

So use the public data as a floor, not a ranking. Is the clinic reporting at all? Do its numbers look plausible for the patients it serves? Treat a glossy in-house statistic that isn't in the federal data with caution — the audited version is the one that counts.

Be wary of add-ons pitched to prevent miscarriage

Recurrent-loss patients are frequently offered preimplantation genetic testing for aneuploidy, or PGT-A, on the promise that screening embryos will stop the miscarriages. The evidence is more modest than the pitch. ASRM's position is that PGT-A's value as a routine screen for all IVF patients has not been demonstrated, and recent multicenter trials found similar overall pregnancy outcomes with and without it 2Ref 2Practice Committees of ASRM and SART (2024).The use of preimplantation genetic testing for aneuploidy: a committee opinion.That the value of PGT-A as a routine screen for all IVF patients has not been demonstrated, and recent multicenter trials found similar overall pregnancy outcomes with and without it.. That does not make it useless in every situation, but a clinic that presents it as a guaranteed fix is overselling.

A clinic that frames any add-on as a guaranteed cure for miscarriage is telling you how it sells, not how it heals. Ask how a recommended extra applies to your specific history, what it costs, and what the evidence actually shows. The answer, and the willingness to give one, is part of what you are evaluating.

What embryo-transfer advice reveals about a clinic

After losses, transferring two embryos to improve the odds can feel like the obvious move, and some clinics will oblige. Current ASRM and SART guidance points the other way: elective single-embryo transfer is recommended because moving one, often chromosomally normal, blastocyst yields comparable pregnancy rates with far less risk of twins 3Ref 3Practice Committees of ASRM and SART (2021).Guidance on the limits to the number of embryos to transfer: a committee opinion.That ASRM/SART recommend elective single-embryo transfer because a single, often euploid, blastocyst yields comparable pregnancy rates with far lower risk of multiple gestation.. Twin pregnancies carry higher risks of their own, including preterm birth. A clinic that holds to single-embryo transfer under emotional pressure is showing you disciplined, evidence-led care.

The reverse is also informative. A practice quick to promise better chances through double transfers, without walking you through the added risk, is optimizing for a number rather than for a healthy pregnancy.

How to weigh multi-cycle and refund packages

A string of losses makes multi-cycle and money-back packages especially tempting, and clinics know it. ASRM's ethics guidance says these programs can be offered fairly only when success is defined in advance, when every cost and exclusion — screening, medications — is disclosed, and when the clinic states its own success rates; it also warns that the structure can create incentives to push higher-risk care 4Ref 4Ethics Committee of ASRM (2023).Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion.That refund and risk-sharing IVF programs are ethical only when success is defined in advance and all costs and exclusions are disclosed, and that they can create incentives toward higher-risk care.. For recurrent loss, where more attempts may genuinely help, that math deserves a slow, careful read.

Before signing anything, get the definition of success in writing, ask what is excluded, and confirm how a refund is triggered. A clinic comfortable with those questions is a better sign than a discount.

The questions that matter at a first consult

A first visit is where a clinic reveals its judgment, so bring questions that test it. Honest counseling about age is a good marker: fertility and pregnancy odds decline gradually from about the early thirties and more steeply after 37, and a thoughtful clinic will name that plainly rather than promise around it 5Ref 5American College of Obstetricians and Gynecologists (2025).Anticipatory Counseling Regarding Ovarian-Factor Fertility Decline (Committee Statement No. 22).That fecundity declines gradually from about age 32 and more rapidly after 37, and that clinicians should counsel patients honestly about age-related fertility decline.. Ask how the practice supports patients through grief, and lean on independent resources too — patient-advocacy organizations such as RESOLVE maintain support and coverage guidance you can use on your own 6Ref 6RESOLVE: The National Infertility Association (2024).RESOLVE: The National Infertility Association — Insurance Coverage and Support Resources.That patient-advocacy organizations provide independent support and coverage/financing guidance, and that state fertility-coverage laws vary..

A few things worth raising when you ask at your first fertility consult:

• Whether the practice completes a full recurrent-loss evaluation before recommending treatment
• How it decides on embryo number and any add-ons, and how it explains the evidence
• What emotional and financial support it offers, and what a realistic plan looks like for someone your age

If a visit leaves you feeling rushed or unheard, a fertility second opinion is reasonable and common; so is asking whether virtual fertility clinics could handle the parts of your care that don't require a room. Inclusive, respectful care matters too — lgbtq+ clinic vetting is a fair part of the same conversation. Wanting to be evaluated carefully, and to grieve without being sold to, is a completely reasonable thing to ask of a clinic.